Saturday , May 26 2018
Home / Advisory Board

Advisory Board

  • Aaron I. Vinik, MD, PhD, FCP, MACP

    Aaron I. Vinik, MD, PhD, FCP, MACP

    (Advisory Board Member) Dr. Vinik has brought international recognition to Virginia as a result of his research and recent discovery of a gene, which could prove to be a cure for diabetes. The gene, INGAP (islet neogenesis associated protein) is responsible, either alone or in combination with other factors, for stimulating immature cells in the diabetic pancreas to produce insulin. When INGAP protein was administered to diabetic hamsters it was shown to reverse diabetes in 40% to 50% of animals. Animal studies were followed by human, multi-center clinical studies in both type 1 and type 2 diabetes, carried out by some of the most highly recognized investigators in the country; the results showed that even in type 1 diabetes an increase in C- peptide, (a measure of islet function), could be induced after 3 months of treatment.
  • Anne Peters, MD, CDE

    Anne Peters, MD, CDE

    (Advisory Board Member) Dr. Peters is the director of the USC Clinical Diabetes Program. Dr. Peters received her medical degree from the University of Chicago Pritzker School of Medicine before proceeding to Stanford University Medical Center in Palo Alto, California, to perform her internship and residency in internal medicine. She completed an endocrinology fellowship at Cedars-Sinai Medical Center in Los Angeles. She was in charge of the Comprehensive Diabetes Program at Cedars and then moved to UCLA, where she ran the Clinical Diabetes Program there. Because of an interest in working with the underserved, she subsequently moved to USC.
  • Caroline Apovian, M.D.

    Caroline Apovian, M.D.

    (Advisory Board Member) Caroline Apovian is Professor of Medicine and Pediatrics, in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine, USA. She is also Director of the Center for Nutrition and Weight Management at Boston Medical Center, USA. Dr. Apovian is a nationally and internationally recognized authority on nutrition and has been in the field of obesity and nutrition since 1990. Her current research interests are in: weight loss and its effects on endothelial cell function, adipose cell metabolism and inflammation, research in the bariatric surgery population, and novel pharmacotherapeutic antiobesity agents. She is also an expert in the technique for subcutaneous adipose tissue biopsies, and has been performing these biopsies on research subjects for over 10 years. She was on the expert panel for updating the 2013 AHA/ACC/TOS Clinical Guidelines for the Management of Overweight and Obesity in Adults.
  • Derek LeRoith

    Derek LeRoith

    (Advisory Board Member) Internationally known for his research in Diabetes, Derek LeRoith, MD, PhD, is Professor of Medicine (Endocrinology, Diabetes and Bone Diseases) and Interim Chief of the Hilda & J. Lester Gabrilove Division of Endocrinology, Diabetes and Bones Diseases. Dr. LeRoith received his MD and PhD from the University of Capetown where he also completed his residency and both a research and clinical fellowship in Endocrinology. Prior to joining the faculty of the Icahn School of Medicine at Mount Sinai in 2005, Dr. LeRoith was Chief of the Diabetes Branch at the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. This is the largest program devoted to the study of diabetes within the intramural program of the NIH. He was recruited to Mount Sinai to become the Chief of the Endocrine Division at Mount Sinai as well as the Director of the Metabolism Institute. In 2010 he became the Director of Research for the Division of Endocrinology before returning to his duties as chief in 2015.
  • George Bakris, MD

    George Bakris, MD

    (Advisory Board Member) George L. Bakris, MD, is a member of the National Kidney Foundation’s Board of Directors. He is Professor of Medicine and Director of the American Society of Hypertension’s Comprehensive Hypertension Center at the University of Chicago Medicine. Dr. Bakris received his medical degree from the Rosalind Franklin School of Medicine and completed residency in Internal Medicine at the Mayo Graduate School of Medicine where he also completed a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago.
  • Joshua Neumiller, Pharm.D., CDE, FASCP

    Joshua Neumiller, Pharm.D., CDE, FASCP

    (Advisory Board Member) Joshua J. Neumiller, Pharm.D., CDE, FASCP, is Vice Chair and Associate Professor in the Department of Pharmacotherapy at Washington State University College of Pharmacy in Spokane, Washington. He is a certified diabetes educator and a fellow of the American Society of Consultant Pharmacists. Josh’s research interests involve the management of diabetes and prevention of adverse drug events during transitions in care. He is Editor-in-Chief for Diabetes Spectrum, a journal of the American Diabetes Association (ADA). He also is a contributing author for the ADA books, Medications for the Treatment of Diabetes, Practical Insulin, and American Diabetes Association Guide to Nutrition Therapy for Diabetes. Josh currently serves on the ADA Professional Practice Committee, which works to update the ADA Standards of Medical Care in Diabetes each year. He was recently awarded the 2016 Albert B. Prescott Pharmacy Leadership Award from the Pharmacy Leadership and Education Institute for his work in diabetes care and education.
  • Lawrence A. Lavery

    Lawrence A. Lavery

    (Advisory Board Member) A medical professor, noted researcher, international lecturer and inventor, Dr. Lawrence Lavery is considered one of the world’s leading experts in diabetic foot complications. He develops highly specialized educational and instructional courses at the national and international level, while also serving as professor of surgery at the Texas A&M Health Science Center College of Medicine and Scott and White Memorial Hospital in Temple, Texas.
  • Louis J. Aronne, MD, FACP

    Louis J. Aronne, MD, FACP

    (Advisory Board Member) Louis J. Aronne, MD, FACP is a leading authority on obesity and its treatment. He is the Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College where he directs the Comprehensive Weight Control Center. He has an adjunct Associate Professor of Clinical Medicine appointment at Columbia University. Dr. Aronne is Founder and CEO of BMIQ, a cloud-based weight management system that is delivered by health care providers to their patients during office visits. Dr. Aronne graduated Phi Beta Kappa from Trinity College with a BS in biochemistry and from Johns Hopkins University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine, followed by a Kaiser Foundation Fellowship at Weill-Cornell. He is a member of the AOA Medical Honor Society.
  • Louis Philipson, MD, PhD

    Louis Philipson, MD, PhD

    (Advisory Board Member) Louis Philipson, MD, PhD, is an endocrinologist and a leading world authority on diabetes mellitus. His clinical interests include type 1 diabetes, complicated type 2 diabetes, monogenic diabetes and hypoglycemia. Recognized for unmatched expertise in the treatment of diabetes that is difficult to manage, Dr. Philipson’s multisciplinary team frequently accepts referrals and provides consultations. Under his leadership, Kovler Diabetes Center has been recognized as a one of only seven National Institutes of Health (NIH) Diabetes Research and Training Centers in the U.S.
  • Maria Emanuel Ryan, DDS, PhD

    Maria Emanuel Ryan, DDS, PhD

    (Advisory Board Member) Dr. Maria Emanuel Ryan, a Stony Brook School of Dental Medicine graduate, is a tenured full Professor in the Department of Oral Biology and Pathology at the School of Dental Medicine and a member of the Medical Staff at University Hospital at Stony Brook University Medical Center. She also serves as the Associate Dean for Strategic Planning and External Affairs. Dr. Ryan received her specialty training in periodontics at the University of Connecticut Health Center, and her Ph.D in Oral Biology and Pathology at Stony Brook. Dr. Ryan is actively involved in teaching, practice and research and served as the Director of Clinical Research. She currently serves on several scientific, dental and medical advisory boards.
  • Michael R. Cohen, RPh, MS, ScD, FASHP

    Michael R. Cohen, RPh, MS, ScD, FASHP

    (Advisory Board Member) Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), is president of The Institute for Safe Medication Practices, a non-profit healthcare organization that specializes in understanding the causes of medication errors and providing error-reduction strategies to the healthcare community, policy makers, and the public. He is editor of the textbook, Medication Errors (2007 American Pharmaceutical Association) and serves as co-editor of the ISMP Medication Safety Alert! publications that reach over 2 million health professionals and consumers in the US, as well as regulatory authorities and others in over 30 foreign countries. He is editor for the ISMP consumer website, and writes a weekly blog for the Philadelphia Inquirer website,, which also appears occasionally in the newspaper. Dr. Cohen currently serves as Vice Chair of the Patient Safety Advisory Group for the Joint Commission (which creates the National Patient Safety Goals). He also served recently as a member of the National Quality Forum’s Voluntary Consensus Standards Maintenance Committee (CSMC) on Safe Practices and serves as a consultant to the US Food and Drug Administration’s Drug Safety and Risk Management Committee. In 2005 he was recognized as a MacArthur Fellow by the John D. and Catherine T. MacArthur Foundation.
  • Paul Chous, M.A., O.D.

    Paul Chous, M.A., O.D.

    (Advisory Board Member) Dr. Paul Chous received his undergraduate education at Brown University and the University of California at Irvine, where he was elected to Phi Beta Kappa in 1985. He received his Masters Degree in 1986 and his Doctorate of Optometry in 1991, both with highest honors from the University of California at Berkeley. Dr. Chous has practiced optometry with a special emphasis on diabetic eye disease and diabetes education for 20 years in the State of Washington, winning the American Diabetes Association’s Distinguished Public Service Award in 1998.
  • Richard K. Bernstein, MD, FACE, FACN, FACCWS

    Richard K. Bernstein, MD, FACE, FACN, FACCWS

    (Advisory Board Member) Dr. Bernstein has been a type 1 diabetic since the age of twelve. He trained as a management engineer (Columbia University School of Engineering & Applied Science, B.S., 1955) and his first career was as a business executive. In 1969, while suffering from several diabetes complications, he was looking for a way to normalize his blood sugars. He aquired a device used in emergency rooms to measure blood sugars at night when the labs were closed. He then began to measure his blood sugar throughout the day, hoping to discover what made it go up and down. This led to the development of “self-monitoring of blood glucose,” a simple procedure that uses one drop of finger tip blood. The technique has since become widely accepted by the medical profession throughout the world.
  • R. Keith Campbell, Professor, B.Pharm, MBA, CDE

    R. Keith Campbell, Professor, B.Pharm, MBA, CDE

    (Advisory Board Member) R. Keith Campbell is the former Associate Dean and is the Distinguished Professor in Diabetes Care/Pharmacotherapy at the Washington State University College of Pharmacy in Pullman, Washington. He has been a member of the faculty since 1968. Keith is distinguished as being one of the first pharmacists to become a CDE (Certified Diabetes Educator) and has encouraged 100’s of pharmacists to become certified as CDE’s. Keith has truly changed the way pharmacists practice pharmacy. He is an active diabetes educator and is involved in numerous diabetes-related activities. He was the Chair of the Medical Advisory Board for the Washington State Diabetes Control Project funded by the Center for Disease Control. He has served on numerous committees for the American Diabetes Association, the American Association of Diabetes Educators, and the NIH. He was a member of professional panels that wrote the position statements on Blood Glucose Monitoring for both ADA and AADE and assisted the NIH in translating the famous Diabetes Control and Complications Trial to try to change the treatment objectives of diabetes patients. He has a personal interest in diabetes having had Type 1 diabetes for over 61 years. He has used an insulin pump for over 32 years.
  • Dr. Sheri Colberg, Ph.D., FACSM

    Dr. Sheri Colberg, Ph.D., FACSM

    (Advisory Board Member) Sheri Colberg, PhD, also known as Sheri Colberg-Ochs, is an author, exercise physiologist, and professor emerita of exercise science at Old Dominion University and a former adjunct professor of internal medicine at Eastern Virginia Medical School, both in Norfolk, Virginia. Having earned her undergraduate degree from Stanford University and a Ph.D. from the University of California, Berkeley, she has specialized in research on diabetes and exercise and healthy lifestyles and shaped physical activity recommendations for professional organizations, including the American College of Sports Medicine, American Diabetes Association, and American Association of Diabetes Educators. She has authored 11 books, along with 24 book chapters and more than 300 articles on physical activity, diabetes, healthy lifestyles, and aging. In addition to her educational website, Diabetes Motion (, she is also the founder of an academy for fitness and other professionals seeking continuing education enabling them to effectively work with people with diabetes and exercise: Diabetes Motion Academy ( These and her own website ( offer additional information about being active with diabetes. She is the 2016 recipient of the American Diabetes Association’s Outstanding Educator in Diabetes Award.
  • Stanley Schwartz, MD, FACP, FACE

    Stanley Schwartz, MD, FACP, FACE

    (Advisory Board Member) Dr. Schwartz has been awarded the honor of being a TOP DOC by Philadelphia Magazine many times over the years, including 2009, 2010 and 2011 for the treatment of diabetes and metabolic syndrome. For over 30 years, Dr. Schwartz was an Associate Professor at the University of Pennsylvania, most recently directing the Diabetes Program at the Philadelphia Heart Institute. Dr. Schwartz actively lectures nationally as well as internationally about diabetes and its treatment. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials.